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Zygomycosis (mucormycosis) is an opportunistic fungal 
infection caused by fungi of the class Zygomycetes order 
Mucorales. Most human infections are caused by Rhizo- 
pus, Mucol; or Absidia, and less commonly Rhizomucol; 
Apophysomyces, Cunninghamella or Saksenaea. It usu- 
ally affects hosts compromised by underlying hemato- 
logic cancer, renal failure, immunosuppressive therapy, 
diabetes mellitus, or burns, and patients receiving defer- 
oxamine. *N In addition, severe zygomycosis can occur in 
infants. Prematurity and malnutrition are common fea- 
tures, and infections are most commonly related to gas- 
trointestinal involvement, with rare dissemination; 
however, primary pulmonary, cutaneous, and rhinocere- 
bra1 involvement have been described. Gastrointestinal 
zygomycosis has been almost uniformly fatal in both chil- 
dren and adults.“,‘” Usually, clinical involvement in adults 
includes the classic rhinocerebral, invasive, pulmonary, 
disseminated or intestinal disease.i,l’-‘” More recent 
reports have shown that primary cutaneous mucormy- 
cosis has emerged as an important form of the dis- 
ease.15-18 Other genera of the class Zygomycetes, for 
example Basidiobolus, have been implicated in primary 
subcutaneous infections in Uganda.Yet these fungi cause 
clinical syndromes clearly different from agents of 
mucormycosis. I9 The use of elasticized adhesive (Elasto- 
plast8) dressing was implicated as a cause of Rhizopus 
infection in the 1970s primarily in patients with under- 
lying immunosuppressive conditions, although a few 
cases were described in previously healthy subjects.2”-22 
Other cases have been related to extensive trauma.23-25 
This report describes two cases of zygomycosis 
related to trauma. These cases presented with unusual 
features. 
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CASE REPORTS 
Patient 1 
A 32-year-old male sustained an injury to his left cheek 
when a wall partially collapsed on him. Except for an 
abrasion on the left cheek, there was no other injury. 
There was no loss of consciousness. Two days follow- 
ing the injury the patient noted pain, redness, and 
swelling around the abrasion. After consulting a physi- 
cian, he was started on oral clindamycin for facial cel- 
lulitis. There was no improvement, and therefore, he 
was admitted to the Aga Khan University Hospital on 
October 28, 1992. The patient had been previously 
healthy and was on no medication. 
Figure 1. Large area of necrosis on the left cheek with minimal serous 
drainage. 
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Figure 3. Pantomograph showing an osteolytic lesion of the left body 
of the mandible with absorotion of teeth. 
Figure 2. Broad, thin-walled, irregularly contoured branched hyphae 
present consistent with mucormycosis (H&E, original magnification 
X100). 
On examination, the patient was noted to be febrile 
at 38°C with swelling and erythema of the left side of his 
face, a central necrotic area and a small amount of serous 
discharge but no pus (Figure 1). The area was tender to 
touch. The rest of his physical examination was unre- 
markable. On admission, pertinent laboratory tests 
included a total white blood cell count (WBC) of 26,000, 
with 83% neutrophils and 7% lymphocytes; hemoglobin 
of 14.4; creatinine of 0.7; sodium (Na) 137; potassium (K) 
3.5; and normal serum glucose and bicarbonate levels. 
Skull and chest radiographs were unremarkable. Parenteml 
clindamycin, metronidazole, and amikacin were started. 
On pantomography there was an area of lucency at the 
root of the first right lower molar but no other abnor- 
mality. Superficial cultures of the serous discharge were 
negative. Cultures from the oral cavity grew Candida 
tropicalis. On November 11,1992, the patient underwent 
surgical debridement, and tissue was sent for mycology 
and histopathology. In spite of antibiotic treatment, the 
necrotic area continued to increase in size. Cultures grew 
Rhizopus species, and histopathology demonstrated gan- 
grenous inflammation with extensive fungal infiltration 
(Figure 2). 
Amphotericin was started at 1 mg/kg per day. 
Although the patient continued to complain of pain, there 
was a decrease in swelling and erythema over the week. 
Repeat WBC on November 16,1992, showed a WBC of 
9,300 with 60% neutrophils and 35% lymphocytes; hemo- 
globin of 10.5; and creatinine of 0.2. The ear, nose, and 
throat surgeon decided on split thickness grafting over 
the left cheek wound, which showed granulation. Cul- 
tures were all negative. The graft was subsequently 
reported as having taken well. Amphotericin B was con- 
tinued up to a total dose of 2 grams. The patient insisted 
on discharge. Three months later, he presented with a l- 
week history of swelling and redness over the graft and 
a 2-day history of severe pain and pus oozing from the 
lower part of the lesion. On examination the patient was 
afebrile and trismic. Intraorally there was mucosal edema. 
Laboratory tests showed a hemoglobin of 11.6, total WBC 
of 10.2 with 63% neutrophils and 33% leukocytes. Cul- 
tures of pus were negative. Repeat pantomography 
showed extensive destruction of the left mandible (Fig- 
ure 3). The patient was scheduled for surgery and ampho- 
tericin B was restarted at I mg/kg per day; however, after 
2 days the patient left the hospital against medical advice. 
No further follow-up was available. 
Patient 2 
A 25-year-old previously healthy male was admitted to 
the Aga Khan Hospital on December 20,1991, with inabil- 
ity to move all four extremities following a road traffic 
accident. There was no history of loss of consciousness; 
examination confirmed a level at C4 vertebra and quad- 
riplegia. A small abrasion was noted on the forehead, but 
there was no other injury. Chest radiograph and skull 
films were normal (Figure 4,A), and computed tomogra- 
phy (CT) of the cervical spine demonstrated a grossly 
comminuted fracture of C5 and ~6 with posterior sub- 
luxation of C4 and cord compression. Pertinent laboratory 
tests were a hemoglobin of 16.4 g/L, a WBC of 10,100 
with 80% neutrophils and 18% lymphocytes, and normal 
electrolytes and blood sugar as well as renal and liver 
function. 
The patient was started on DecadronB (4 mg every 
6 hr) and cervical traction. Three days later, the patient 
was noted to be febrile and complained of pain at the site 
of the abrasion. Cloxacillin (2 g every 6 hr) was started 
parenterally. The area around the abrasion became red 
and tender with a central necrotic area that increased in 
size over the next 2 days. The area was debrided under 
general anesthesia. Cultures obtained during surgery of 
the debrided tissue grew Rhizopus species. Decadron 
was stopped and amphotericin started at 1 mg/kg per 
day. The patient tolerated amphotericin B poorly, with 
chills and fever, and insisted on several occasions that 
the antifungal agent be held for a few days. Therefore, 
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Figure 4. Skull radiographs. A, December 20, 1991, normal skull; 6, 
May 1, 1992, lgic lesion of the frontal bone, 
after receiving daily therapy for 2 weeks, he received a 
total dose of 1 gram over the next 4 months. However, 
despite therapy, the necrotic margins of the area contin- 
ued to extend, requiring repeated surgical debridement. 
Finally, a repeat skull radiograph on May 1,1992, demon- 
strated numerous lucent defects consistent with fungal 
involvement (Figure 4, B). The infected bone was surgi- 
cally removed, the fungal tissue debulked, and the dura 
repaired. Cultures obtained at surgery again grew Rhi- 
zopus, and pathology confirmed invasive zygomycosis. 
The patient subsequently received an additional 2 grams 
of amphotericin B. Three months later, when readmitted 
for elective cranioplasty he had no evidence of fungal 
infection and was discharged after a few days. When last 
seen in February 1993, he was doing well. 
MATERIALS AND METHODS 
Mycology 
Specimens were streaked heavily in duplicate onto 
Sabouraud dextrose agar (oxoid code CM42, Oxoid Ltd., 
UK) and Sabouraud with 2% dextrose containing chlo- 
ramphenicol and polymyxin B (chloramphenicol 0.05 
g/L; polymyxin B 0.1 g/L). The plates were incubated at 
25°C and 37°C under aerobic condition. The growth of 
Rhi.zopus was observed in 2 to 3 days. The mold grew 
rapidly and filled the petri dish with grayish-white 
mycelium. Identification by macroscopic and microscopic 
examination was performed as previously described.2” 
DISCUSSION 
The Zygomycetes are widespread in nature, living on 
decaying vegetation and organic materials. Asexual spo- 
rangiospores are the infective particles, and direct inoc- 
ulation occurs into wounds. Organisms germinate in 
tissues, and invasive mycelial forms with thick non- 
septate hyphae spread preferentially in the lumen of 
blood vessels, leading to ischemia and infarction of tis- 
sue. The angioinvasiveness of this fungus determines 
the rapid progression of necrosis, as seen in the cases 
presented here.‘,x 
Progressive infection with Zygomycetes in normal 
hosts is rare. Keys and colleagues first described a noso- 
comial outbreak of skin and subcutaneous Rhizopus 
oryzae infection in six patients complicating the use of 
Elastoplast bandage.21 This was later confirmed by Garten- 
berg and co-workers, who grew i2fucor from an Elasto- 
plast strip.23 Johnson and colleagues reported three cases 
in nondiabetic patients with extensive trauma, all of 
whom developed rapidly progressive severe wound infec- 
tions caused by Rbizopus species.‘” Two cases of wound 
zygomycosis attributable to Rhizopus species were 
described in healthy adults by Vainrub and colleagues; 
however, these patients had extensive soft tissue damage 
together with soil contamination.z5 The authors postu- 
lated that devitalization of tissue allowed for germination 
of organisms. Although detailed immunologic parameters 
were not available, white blood cell function, 
immunoglobulin levels, and metabolic parameters were 
normal in these patients, and there was no history of use 
of alcohol or immunosuppressive therapy. Many recently 
reported cases of wound zygomycosis in immunocom- 
petent patients have been caused by Apophysomyces ele- 
guns or Saksenaea vasiformis.” 
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Weinberg and co-workers noted the frequency of 
invasive cellulitis attributable to Apophysomyces elegans 
in immunocompetent hosts as opposed to that caused 
by other species. Inoculation generally followed local 
trauma with definite or possible contamination from soil 
and occurred predominantly in warmer areas.2x Con- 
tiguously spread osteomyelitis attributable to zygomycetes 
is rare and is difficult to treat. Meis and colleagues 
describe an immunocompetent patient with trauma-intro- 
duced zygomycosis. Despite 7.9 grams of amphotericin 
B, the patient required an interthoracoscapular amputa- 
tion because of rapid spread of infection.29 
In a previous review of 117 patients with cutaneous 
zygomycosis, local factors (i.e., surgery, burns, motor 
vehicle-related trauma, spider bites) were associated 
with most cases, 50% of patients who did not have sys- 
temic illnesses, 97% had local risk factors.‘” The two 
patients presented here did not have any systemic ill- 
nesses, obvious immune defects, or extensive local 
trauma. In these two cases, neutrophil function tests 
could not be done because of the expense involved. 
However, the patients were on no medications and had 
not had frequent previous infections. Metabolic para- 
meters were normal. Neutrophils are the most important 
component of the host response to Zygomycetes. As yet 
undefined defects of macrophages and neutrophils pre- 
sent in diabetic and steroid-treated patients allow repli- 
cation of the fungus.’ There are few cases in patients 
with human immunodeficiency virus (HIV), attesting to 
the importance of the neutrophil. Nevertheless, HIV test- 
ing was not done in the patients presented here. In a 
recent review of cases, Sanchez and colleagues noted 
that eight of ten HIV-positive patients with zygomyco- 
sis were intravenous drug users.j” Cutaneous infections 
occurred in four of their patients. Nagy-Agren and CO& 
leagues reviewed 15 HIV-positive patients with zygomy- 
cosis. The majority of patients had a history of 
intravenous drug use and several had episodes of neu- 
tropenia.“’ 
Of interest, one of the patients presented here sus- 
tained minimal trauma with no fractures and only an abra- 
sion of the cheek. The second patient had serious trauma 
and quadriplegia, yet the abrasion on his forehead was 
almost imperceptible at the time of admission. However, 
he did receive steroids for 3 days, which may have pre- 
disposed him to invasive fungal disease.32 
That cutaneous mucormycosis is rare cannot be 
explained by lack of exposure to the infecting spores, 
because they are ubiquitous. It remains possible that 
suppression of immune responses by acute trauma 
enables this sequence of events in otherwise normal 
hosts. The lung was unlikely to be a portal of entry, 
because skin involvement secondary to disseminated 
mucormycosis is widespread, involving many other 
organs besides the lungs. 13,33 The present cases indicate 
that when progressive necrosis at the margin of a 
wound is noted, a diagnosis of invasive zygomycosis 
should be considered and is likely if appropriate antibi- 
otic therapy for bacterial pathogens is ineffective. Cul- 
ture and histologic examination of biopsied tissue taken 
from the margin of the wound is diagnostic. The prog- 
nosis for cutaneous mucormycosis is distinctly better 
than that of other forms. However, long-term morbidity 
and mortality rates are still high. Many patients require 
amputation of affected extremities.16 Treatment requires 
an aggressive combined surgical and medical approach. 
Surgical treatment is important. Review of cases revealed 
that death resulted from extension of the infection into 
vital regions. Once local control had been attained, 
relapse rarely occurred. I6 Amphotericin B is the only 
agent thought to have activity against Mucorales. Occa- 
sional response to amphotericin B administered alone 
suggests that use of this drug is beneficiaL3* Higher than 
usual doses of amphotericin B have been recommended. 
Interpretation of in vitro susceptibility tests is prob- 
lematic.35 There is a lack of standardization of suscep- 
tibility testing. Reliable in vitro susceptibilty data are 
available for yeasts and not for molds, such as zygomy- 
cosis.36 Eng and colleagues found that most strains, 
including Rhizopus, were inhibited but not killed by 
0.5 pg/mL of amphotericin B. In serum, all were resis- 
tant to the imidazoles.35 Christenson and co-workers 
found synergistic activity of amphotericin B and 
rifampin against Rhizopus in vitros3’ However confir- 
matory in vivo data are scarce. 
In patient 1,3 grams of amphotericin B were used in 
daily doses of 1 mg/kg, yet relentless progression 
occurred. Several newer antifungal agents that are not 
yet available in conjunction with cytokines may show 
promise for the future.. 38,39 As these cases illustrate, an 
immunologic defect may not be evident, and the intro- 
duction of spores into devitalized tissue in the setting of 
trauma and, in particular, with the use of steroids for a few 
days, may be sufficient for invasion. 
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